Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue of BMJ Open.
NICE has asked Bristol Myers Squibb, who manufacture nivolumab (Opdivo), to provide more information on its effectiveness for treating Hodgkin lymphoma…